XWELL, Inc. (XWEL)
CIK 1410428 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 8.4M shares as of May 14, 2026 (10-Q). Share count fell from 83.5M to 4.2M between Aug 10, 2023 and Nov 9, 2023, a pattern consistent with a reverse split (roughly 1-for-20); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.
Cash runway
Going-concern warning
auditor flagged substantial doubt
The company itself flagged going-concern doubt in a filing.
Full breakdown: cash runway tool · source filing →
Warrants
| Tranche | Warrants | Exercise price | Term | Notes |
|---|---|---|---|---|
| Series H Placement Agent Warrants | 5.3M | not tagged | 5y | — |
| Series H Warrants | not tagged | not tagged | 3y | — |
Tranches exactly as the company dimensioned them in its 10-Q filed May 20, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
Warrants outstanding: 72.0M underlying shares, as reported Mar 31, 2026 (10-Q).
Reported exercise price: $1.7 (aggregate figure as tagged; individual tranches vary).
Balance-sheet fair value of warrants: $2.7M as of May 16, 2025.
Down-round (price protection) accounting has been tagged in this filer’s XBRL: some instrument carries repricing protection. Which tranche requires reading the exhibits.
Rough fully diluted estimate: 80.4M = 8.4M O/S + 72.0M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
Convertible debt on the balance sheet: $3.6M as of Dec 31, 2025, tagged only as a company-wide total.
This filer tagged totals without per-note dimensions in its 10-Q filed May 20, 2026 →, so per-note terms (maturities, individual conversion prices) live in the exhibit prose and are not parsed here.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 8.4M | May 14, 2026 |
| + Series H Placement Agent Warrants (if exercised) | 5.3M | Feb 24, 2026 |
| Fully diluted estimate | 13.8M | +63.2% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Registered offering capacity on live registrations: $154.3Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted
Last 12 months: 3 executed · 1 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full XWEL workspace